Dataset Information

Triggering of inflammasome by aggregated ?-synuclein, an inflammatory response in synucleinopathies.

ABSTRACT: Parkinson's disease (PD) is one of the most common neurodegenerative diseases. It is characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta of the brain. Another feature is represented by the formation in these cells of inclusions called Lewy bodies (LB), principally constituted by fibrillar ?-synuclein (?Syn). This protein is considered a key element in the aetiology of a group of neurodegenerative disorders termed synucleinopathies, which include PD, but the cellular and molecular mechanisms involved are not completely clear. It is established that the inflammatory process plays a crucial role in the pathogenesis and/or progression of PD; moreover, it is known that aggregated ?Syn, released by neurons, activates microglia cells to produce pro-inflammatory mediators, such as IL-1?. IL-1? is one of the strongest pro-inflammatory cytokines; it is produced as an inactive mediator, and its maturation and activation requires inflammasome activation. In particular, the NLRP3 inflammasome is activated by a wide variety of stimuli, among which are crystallized and particulate material. In this work, we investigated the possibility that IL-1? production, induced by fibrillar ?Syn, is involved the inflammasome activation. We demonstrated the competence of monomeric and fibrillar ?Syn to induce synthesis of IL-1?, through TLR2 interaction; we found that the secretion of the mature cytokine was a peculiarity of the fibrillated protein. Moreover, we observed that the secretion of IL-1? involves NLRP3 inflammasome activation. The latter relies on the phagocytosis of fibrillar ?Syn, followed by increased ROS production and cathepsin B release into the cytosol. Taken together, our data support the notion that fibrillar ?Syn, likely released by neuronal degeneration, acts as an endogenous trigger inducing a strong inflammatory response in PD.

SUBMITTER: Codolo G

PROVIDER: S-EPMC3561263 | biostudies-literature | 2013

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Triggering of inflammasome by aggregated α-synuclein, an inflammatory response in synucleinopathies.

Codolo Gaia G Plotegher Nicoletta N Pozzobon Tommaso T Brucale Marco M Tessari Isabella I Bubacco Luigi L de Bernard Marina M

PloS one 20130131 1

Parkinson's disease (PD) is one of the most common neurodegenerative diseases. It is characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta of the brain. Another feature is represented by the formation in these cells of inclusions called Lewy bodies (LB), principally constituted by fibrillar α-synuclein (αSyn). This protein is considered a key element in the aetiology of a group of neurodegenerative disorders termed synucleinopathies, which include PD, but the ce ...[more]

PMID: 23383169

Similar Datasets

Project description:Parkinson's disease (PD) is a progressive neurodegenerative disorder that is neuropathologically characterized by degeneration of dopaminergic neurons of the substantia nigra (SN) and formation of Lewy bodies and Lewy neurites composed of aggregated α-synuclein. Proteolysis of α-synuclein by matrix metalloproteinases was shown to facilitate its aggregation and to affect cell viability. One of the proteolysed fragments, Gln79-α-synuclein, possesses a glutamine residue at its N-terminus. We argue that glutaminyl cyclase (QC) may catalyze the pyroglutamate (pGlu)79-α-synuclein formation and, thereby, contribute to enhanced aggregation and compromised degradation of α-synuclein in human synucleinopathies. Here, the kinetic characteristics of Gln79-α-synuclein conversion into the pGlu-form by QC are shown using enzymatic assays and mass spectrometry. Thioflavin T assays and electron microscopy demonstrated a decreased potential of pGlu79-α-synuclein to form fibrils. However, size exclusion chromatography and cell viability assays revealed an increased propensity of pGlu79-α-synuclein to form oligomeric aggregates with high neurotoxicity. In brains of wild-type mice, QC and α-synuclein were co-expressed by dopaminergic SN neurons. Using a specific antibody against the pGlu-modified neo-epitope of α-synuclein, pGlu79-α-synuclein aggregates were detected in association with QC in brains of two transgenic mouse lines with human α-synuclein overexpression. In human brain samples of PD and dementia with Lewy body subjects, pGlu79-α-synuclein was shown to be present in SN neurons, in a number of Lewy bodies and in dystrophic neurites. Importantly, there was a spatial co-occurrence of pGlu79-α-synuclein with the enzyme QC in the human SN complex and a defined association of QC with neuropathological structures. We conclude that QC catalyzes the formation of oligomer-prone pGlu79-α-synuclein in human synucleinopathies, which may-in analogy to pGlu-Aβ peptides in Alzheimer's disease-act as a seed for pathogenic protein aggregation.

Dataset Information

Triggering of inflammasome by aggregated ?-synuclein, an inflammatory response in synucleinopathies.

Publications

Triggering of inflammasome by aggregated α-synuclein, an inflammatory response in synucleinopathies.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets